4//SEC Filing
Thye Dirk 4
Accession 0001415889-24-001313
CIK 0001662774other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:48 PM ET
Size
11.1 KB
Accession
0001415889-24-001313
Insider Transaction Report
Form 4
Thye Dirk
DirectorCEO and CMO
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2024-01-16−149,999→ 450,001 totalExercise: $0.94Exp: 2033-01-31→ Common Stock (149,999 underlying) - Exercise/Conversion
Common Stock
2024-01-16$0.94/sh+149,999$140,999→ 689,441 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-01-16−90,531→ 115,860 totalExercise: $0.55Exp: 2022-03-27→ Common Stock (90,531 underlying) - Exercise/Conversion
Common Stock
2024-01-16$0.55/sh+90,531$49,792→ 539,442 total
Footnotes (2)
- [F1]The shares subject to the option shall vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments over the following three years.
- [F2]The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2023, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date.
Documents
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001638945
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 4:48 PM ET
- Size
- 11.1 KB